DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis.

TAVR 111

TAVR Stenosis Aortic Aortic valve 111

AMS Cardiology

APRIL 16, 2024

If you’ve been diagnosed with aortic stenosis, you might have come across the term TAVR. If you’re wondering “ What is TAVR ?” our blog aims to clearly outline this procedure and how it can significantly improve your quality of life. Who Is a Candidate for TAVR? TAVR is not a one-size-fits-all solution.

Aortic valve 52

Aortic valve TAVR Aortic Open-Heart Surgery 52

DAIC

APRIL 9, 2024

The SMART trial is the first randomized head-to-head comparison of the two most widely used TAVR devices—the supra-annular self-expanding Evolut PRO/PRO+/FX and the balloon-expandable SAPIEN 3/3 Ultra. The trial enrolled 716 patients who underwent TAVR at 83 international sites in North America, Europe and the Middle East.

TAVR 59

TAVR Aortic valve Aortic Anatomy 59